Related Experiment Videos

Interventions to promote optimal health outcomes in children with Type 1 diabetes--are they effective?

E A Northam1, S Todd, F J Cameron

  • 1Department of Psychology, University of Melbourne, Melbourne, Vic., Australia. lis.northam@rch.org.au

Diabetic Medicine : a Journal of the British Diabetic Association
|January 26, 2006
PubMed

Insights

Type 1 diabetes is rising globally, impacting quality of life. Effective interventions are needed for children facing psychological issues and poor metabolic control, but current studies have limitations.

Area of Science:

  • Pediatric Endocrinology
  • Child Psychology
  • Public Health

Background:

  • Type 1 diabetes incidence is increasing worldwide, leading to significant public health costs and reduced quality of life.
  • Children with diabetes exhibit higher rates of psychological problems, often linked to poorer metabolic control.
  • Emerging research identifies risk factors for this dual morbidity in pediatric diabetes patients.

Purpose of the Study:

  • To review the existing intervention literature for children with Type 1 diabetes at risk for adverse mental and physical health outcomes.
  • To identify gaps and limitations in current interventions.
  • To suggest directions for future research and intervention development.

Main Methods:

  • Systematic review of intervention studies focusing on psychological and metabolic outcomes in children with Type 1 diabetes.
  • Analysis of intervention characteristics, including target population (age), intervention type (diabetes-specific vs. standardized), and methodology.
  • Identification of methodological limitations in existing studies.

Main Results:

  • Most reviewed interventions were diabetes-specific and unstandardized, primarily targeting adolescents.
  • Few interventions have been tested in younger children.
  • No studies specifically targeted common psychological disorders like behavior problems or depression in this population.
  • Methodological limitations were prevalent across many studies.

Conclusions:

  • There is a critical need for effective, standardized interventions for children with Type 1 diabetes, particularly targeting specific psychological disorders.
  • Future research should address methodological limitations and focus on a broader age range and specific psychological conditions.
  • Improving interventions can reduce the overall burden of illness in children with Type 1 diabetes.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...